AARD vs ATO · $284.4M cap vs P/E 22, rev $4.70B
Aardvark Therapeutics, Inc. Common Stock (AARD) versus Atmos Energy Corporation (ATO) — a side-by-side from cached financials, not a winner call.
Aardvark Therapeutics, Inc. Common Stock (AARD) is a biotechnology company listed on US.
Atmos Energy Corporation (ATO) is a utilities - regulated gas company listed on US.
Latest reported AARD revenue for 2025-12-31 was $0. Net income was -$57.6M. Revenue was down 100.0% from 2024-12-31 to 2025-12-31. AARD currently screens at market cap $284.4M.
Latest reported ATO revenue for 2025-09-30 was $4.70B. Net income was $1.20B. ATO currently screens at market cap $24.52B and trailing P/E 21.6.
AARD currently screens at market cap $284.4M. ATO currently screens at market cap $24.52B and trailing P/E 21.6.
Not investment advice. Open the AARD and ATO stock pages for the full models.
Not investment advice.